We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by Charite University, Berlin, Germany.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: May 11, 2007
Last Update Posted: May 11, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Charite University, Berlin, Germany
Sudden cardiac death is the most frequent cause of death in industrialized countries. The most efficient interventiont in ventricular fibrillation is defibrillation in an appropriate timely manner. But since the intervention of defibrillation the optimal shock energy is unknown. As a too low energy is not able to terminate ventricular fibrillation a too high energy may cause asystole wich jeopardizes survival itself. We study the efficacy of different shock energies on the termination of ventricular fibrillatiion and survival.

Condition Intervention
Sudden Cardiac Death Arrhythmia Survival Procedure: shock efficacy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • termination of vf survival

Secondary Outcome Measures:
  • resulting rhythm CPC score


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • out of hospital sudden cardiac death
  • ventricular fibrillation

Exclusion Criteria:

  • non cardiac death
  • asystole
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472147

Contact: Dirk Müller, MD, PhD +49 30 8445 ext 3554 dr.dirk.mueller@charite.de
Contact: Hans-Richard Arntz, MD, PhD +49 30 8445 ext 2640 hans-richard.arntz@charite.de

Charité campus Benjamin Franklin
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Principal Investigator: Dirk Müller, MD, PhD Charite University, Berlin, Germany
  More Information

ClinicalTrials.gov Identifier: NCT00472147     History of Changes
Other Study ID Numbers: CBF-2007002
First Submitted: May 10, 2007
First Posted: May 11, 2007
Last Update Posted: May 11, 2007
Last Verified: May 2007

Additional relevant MeSH terms:
Out-of-Hospital Cardiac Arrest
Death, Sudden, Cardiac
Pathologic Processes
Heart Arrest
Heart Diseases
Cardiovascular Diseases
Death, Sudden